Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma.
- Author:
Jia-Ni WANG
1
;
Quan-Hui QIAO
2
;
Xing-Sheng HU
1
;
Yu-Tao LIU
1
;
Zhi-Jie WANG
1
;
Jian-Chun DUAN
1
;
Yu FENG
1
;
Hao-Hua ZHU
1
Author Information
- Publication Type:Journal Article
- From: Chinese Medical Journal 2021;134(17):2119-2121
- CountryChina
- Language:English
